Empro Group Inc. (EMPG)
Healthcare · NCM
Price as at 10 Aug 2026, 21:42 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Empro Group Inc. trades at $17.36, which is 60% above the $6.94 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.
Our moat model scores it 67 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 192.9 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
EMPG passes 2 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
EMPG peers
The largest companies in the same industry (Medical Distribution), then in the same sector.
- COR Cencora, Inc.
- EBO.AX EBOS Group Limited
- AHG Akso Health Group
- NOVO-B.CO Novo Nordisk
- LLY Eli Lilly and Company
- JNJ Johnson & Johnson
- ABBV AbbVie Inc.
- MRK Merck & Co., Inc.
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is Empro Group Inc. (EMPG) undervalued?
Against our fair value estimate of $6.94, EMPG at $17.36 is 60% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
What is EMPG's P/E ratio?
EMPG trades at 192.9 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
Where does SteadyShares get its EMPG data?
Fundamentals for EMPG come from company filings and exchange data, as listed on NCM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 10 Aug 2026, 21:42 UTC and is delayed. Our data quality score for this company is 88/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for EMPG, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.